secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2023-02-13T23:59:59+00:00
Accession:  0000950170-23-002612
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q4 revenue $32M (+14% YoY); COO Vazquez retiring Apr 3
---------------------------------------------------------------------

- Q4 revenue $32.0M (+14% YoY); full-year revenue $115.4M (+12.4% YoY).
- GAAP gross margin 16.5% (17.1% non-GAAP); operating loss $45.1M.
- Tablo installed base grew 54% YoY to ~4,000 systems; 800 home units.
- FY 2023 guidance reaffirmed: revenue $140-150M, non-GAAP gross margin ~20%.
- COO Martin Vazquez retiring Apr 3, 2023; expected 6-month consulting arrangement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017023002612/0000950170-23-002612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017023002612/om-20230213.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-002612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer